Undated (WXOW) - Alzheimer's disease robs a person's memory and becomes more debilitating
as it progresses.
While there is no known cure, the National Institutes of Health is sponsoring a large-scale clinical trail to find out if an experimental drug can be used to prevent the disease.
It's called Solanezumab a drug designed to rid the brain of plaques and a certain protein called Amyloid associated with Alzheimer's.
Researchers will enroll older individuals for the study who have evidence of that protein marker in their brains, but do not yet show clinical symptoms of the disease.
They hope to show that by starting treatment in high risk individuals before any symptoms are present, and by treating them for longer periods of time, loss of memory will be retarded and ultimately prevent development of Alzheimer's disease.
It is hoped the three-year study might lead to a successful treatment of this looming public health crisis.
All content © Copyright 2000 - 2014 WorldNow and WXOW. All Rights Reserved.
Persons with disabilities who need assistance with issues relating to the content of this station's public inspection file should contact Administrative Assistant Theresa Wopat at 507-895-9969. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, at 888-835-5322 (TTY) or at firstname.lastname@example.org.